Alpha Teknova Inc Asset Resilience Ratio
Alpha Teknova Inc asset resilience ratio. Alpha Teknova Inc (TKNO) has an Asset Resilience Ratio of 14.89% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Alpha Teknova Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Alpha Teknova Inc (2019–2025)
Asset resilience ratio of Alpha Teknova Inc from 2019 to 2025. This chart shows how Alpha Teknova Inc's Asset Resilience Ratio has changed over time. Read how much debt does Alpha Teknova Inc carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Alpha Teknova Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Alpha Teknova Inc (TKNO) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $15.43 Million | 14.89% |
| Total Liquid Assets | $15.43 Million | 14.89% |
Asset Resilience Insights
- Moderate Liquidity: Alpha Teknova Inc has 14.89% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Alpha Teknova Inc Industry Peers by Asset Resilience Ratio
Compare Alpha Teknova Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Alpha Teknova Inc Asset Resilience Ratio by Year (2019–2025)
Alpha Teknova Inc asset resilience ratio by year from 2019 to 2025. The table below shows the annual Asset Resilience Ratio data for Alpha Teknova Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 14.89% | $15.43 Million | $103.58 Million | -7.58pp |
| 2024-12-31 | 22.47% | $26.69 Million | $118.77 Million | -- |
| 2023-12-31 | 0.00% | $0.00 | $128.59 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $166.51 Million | -- |
| 2020-12-31 | 2.88% | $1.81 Million | $62.91 Million | -6.58pp |
| 2019-12-31 | 9.45% | $5.53 Million | $58.51 Million | -- |
About Alpha Teknova Inc
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sam… Read more